Search Results - "Makwana, Jalpa"

  • Showing 1 - 13 results of 13
Refine Results
  1. 1

    Drug Nanocrystals: A Comprehensive Review with Current Regulatory Guidelines by Dhaval, Mori, Makwana, Jalpa, Sakariya, Ekta, Dudhat, Kiran

    Published in Current drug delivery (01-01-2020)
    “…Drug nanocrystals offer an attractive approach for improving the solubility and dissolution rate of poorly soluble drugs which accounts for nearly 40 % newly…”
    Get more information
    Journal Article
  2. 2

    Antifibrinolytics in liver surgery by Makwana, Jalpa, Paranjape, Saloni, Goswami, Jyotsna

    Published in Indian journal of anaesthesia (01-11-2010)
    “…Hyperfibrinolysis, a known complication of liver surgery and orthotopic liver transplantation (OLT), plays a significant role in blood loss. This fact…”
    Get full text
    Journal Article
  3. 3

    Practice of epidural steroid injections outside of the United States by Doshi, Preeti P., MD, DA (UK), FRCA (II), FIPP, Makwana, Jalpa D., MBBS, DA

    “…Spinal pain syndromes are major causes of morbidity and disability globally. Epidural steroid injections (ESIs) play a vital role in the nonsurgical management…”
    Get full text
    Journal Article
  4. 4

    Formulation, evaluation and optimization of the felodipine nanosuspension to be used for direct compression to tablet for in vitro dissolution enhancement by Mori, Dhaval, Makwana, Jalpa, Parmar, Ramesh, Patel, Kalpesh, Chavda, Jayant

    “…The oral bioavailability of felodipine very low, nearly just 15% due to its limited solubility and high first pass metabolism. The present study was aimed to…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7

    Authors' reply by Makwana, Jalpa, Paranjape, Saloni, Goswami, Jyotsna

    Published in Indian journal of anaesthesia (01-05-2011)
    “…We appreciate the interest of the authors and thank them for their comments [1] regarding our article titled "Antifibrinolytics in Liver Surgery"…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13